Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

NCT00238849 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Previously Treated Metastatic Non-Small Cell Lung Cancer

Interventions

DRUG: Oxaliplatin

Sponsor

Integrated Community Oncology Network

Collaborators

[object Object]